Results 191 to 200 of about 78,818 (344)
Understanding time–activity curve and time‐integrated activity variations in radiopharmaceutical therapy challenge: Experience and results
Medical Physics, Volume 52, Issue 10, October 2025.Abstract Background
The process of determining/calculating the time–activity curve (TAC) for radiopharmaceutical therapy (RPT) is generally heavily dependent on user‐ and site‐dependent steps (e.g., the number and schedule of measurement points to be used, selection of the fit function), each having a notable effect on the determination of the time ...Oleksandra V. Ivashchenko, Jim O'Doherty, Deni Hardiansyah, Elisa Grassi, Johannes Tran‐Gia, Johannes W. T. Heemskerk, Eero Hippeläinen, Mattias Sandström, Marta Cremonesi, Gerhard Glatting +9 morewiley +1 more sourceDiffusing alpha‐emitters radiation therapy: In vivo measurements of effective diffusion and clearance rates across multiple tumor types
Medical Physics, Volume 52, Issue 10, October 2025.Abstract Background
Diffusing alpha‐emitters radiation therapy (“Alpha‐DaRT”) is a new modality that uses alpha particles to treat solid tumors. Alpha‐DaRT employs interstitial sources loaded with low activities of 224Ra$^{224}{\rm Ra}$, designed to release a chain of short‐lived alpha‐emitters, which diffuse over a few millimeters around each source ...Mirta Dumančić, Guy Heger, Ishai Luz, Maayan Vatarescu, Noam Weizman, Lior Epstein, Tomer Cooks, Lior Arazi +7 morewiley +1 more sourceConsensus recommendations for hyperpolarized [1‐13C]pyruvate MRI multi‐center human studies
Magnetic Resonance in Medicine, Volume 94, Issue 4, Page 1386-1400, October 2025.Abstract
MRI of hyperpolarized (HP) [1‐13C]pyruvate allows in vivo assessment of metabolism and has translated into human studies across diseases at 15 centers worldwide. To determine consensus on best practice for multi‐center studies for development of clinical applications.Shonit Punwani, Peder E. Z. Larson, Christoffer Laustsen, Jan VanderMeulen, Jan Henrik Ardenkjær‐Larsen, Adam W. Autry, James A. Bankson, Jenna Bernard, Robert Bok, Lotte Bonde Bertelsen, Jenny Che, Albert P. Chen, Rafat Chowdhury, Arnaud Comment, Charles H. Cunningham, Duy Dang, Ferdia A. Gallagher, Adam Gaunt, Yangcan Gong, Jeremy W. Gordon, Ashley Grimmer, James Grist, Esben Søvsø Szocska Hansen, Mathilde Hauge Lerche, Richard L. Hesketh, Jan‐Bernd Hoevener, Ching‐Yi Hsieh, Kayvan R. Keshari, Sebastian Kozerke, Titus Lanz, Dirk Mayer, Mary McLean, Jae Mo Park, Jim Slater, Damian Tyler, Jean‐Luc Vanderheyden, Cornelius von Morze, Fulvio Zaccagna, Vlad Zaha, Duan Xu, Daniel Vigneron, The HP 13C MRI Consensus Group, Lotte Bonde Bertelsen, Nikolaj Bøgh, Esben Søvsø Szocska Hansen, Christoffer Laustsen, Jack Miller, Michael Vaeggemose, Jonas Steinhauser, Ching‐Yi Hsieh, Gigin Lin, Max Fuetterer, Sebastian Kozerke, Albert Chen, Arnaud Comment, Adam Gaunt, Justin Lau, Avi Leftin, Rolf Schulte, Jean‐Luc Vanderheyden, Irene Marco Rius, Jan‐Bernd Hoevener, Thomas C Booth, Mor Mishkovsky, Christopher Michael Walker, Jim Bankson, Kayvan Keshari, Ramona Woitek, Yuhei Takado, Crystal Vasquez, Sebastien Serres, Christoph A. Müller, Joel Floyd, Titus Lanz, Jan Henrik Ardenkjær‐Larsen, Andrea Capozzi, Mathilde Hauge Lerche, Martin Grashei, Franz Schilling, Geoffrey J Topping, Frits van Heijster, Adam Autry, Jenna Bernard, Bob Bok, Myriam Chaumeil, Jenny Che, Duy Dang, Jeremy Gordon, Yaewon Kim, John Kurhanewicz, Peder Larson, Yan Li, Michael Ohliger, Jim Slater, Renuka Sriram, Dan Vigneron, Zhen Jane Wang, Duan Xu, Ashley Grimmer, Mary McLean, Fulvio Zaccagna, Ferdia Gallagher, Rafat Chowdhury, Yangcan Gong, Shonit Punwani, Richard Hesketh, Jeraj Hassan, Andreas Kjaer, Matthew Merritt, Michael Bock, Andreas Schmidt, Dirk Mayer, Myounghee Lee, James Grist, Damian Tyler, Sarah Birkhoelzer, Jordan McGing, Aaron Axford, Oliver Rider, Fatemeh Khashami, Craig Malloy, Jae Mo Park, Vlad Zaha, Sung‐Han Lin, Junjie Ma, Charles Cunningham, Cornelius von Morze +126 morewiley +1 more sourceNew Approaches to Investigate Novel Agents in Ewing Sarcoma: A Report From the Children's Oncology Group Bone Tumor Committee
Pediatric Blood &Cancer, Volume 72, Issue 10, October 2025.ABSTRACT
Outcomes for relapsed Ewing sarcoma remain consistently poor. Continued efforts to consider creative new approaches for the treatment of relapsed Ewing sarcoma are needed. The Children's Oncology Group Bone Tumor Committee convened a New Strategies for Ewing Sarcoma Task Force to systematically evaluate agents for inclusion in future Phase II ...Jessica D. Daley, Susan L. Whiteway, Christine M. Heske, Filemon S. Dela Cruz, Sarah B. Whittle, Sarah Cohen‐Gogo, Anderson B. Collier, Ajay Gupta, Joyce Ohm, Andrew Clark, Alice Soragni, Elizabeth Lawlor, Bhuvana Setty, Patrick J. Grohar, Katie Janeway, Damon R. Reed, Emily K. Slotkin, Kelly M. Bailey +17 morewiley +1 more sourceEvaluation of 64Cu-based radiopharmaceuticals that target Aβ peptide aggregates as diagnostic tools for Alzheimer’s disease [PDF]
, 2017 Bandara, Nilantha, Han, Byung Hee, Krieger, Stephanie, Mirica, Liviu M, Rogers, Buck E, Schultz, Jason W, Sharma, Anuj K +6 morecore +2 more sourcesRecent implications of FAPI PET in cardiac diseases
VIEW, Volume 6, Issue 5, October 2025.Background: FAP, highly expressed in activated cardiac fibroblasts after injury, is the target for FAPI‐based PET imaging.
What was done: This review examines the role of FAPI PET imaging across major cardiac conditions (myocardial infarction, hypertrophic cardiomyopathy, dilated cardiomyopathy, and cardiac amyloidosis) and critically evaluates its ...Lan Wang, Shixing Huang, Fengling Shan, Jingjing Lou, Xingdang Liu +4 morewiley +1 more source
